No holiday for DKSH in Cambodia as it takes on GSK's logistics
This article was originally published in Scrip
The healthcare business division of the Asian contract market expansion group DKSH is to provide a broad range of business services to GlaxoSmithKline in Cambodia, as the UK pharma giant looks to build its product presence in one of Asia's least developed emerging markets.
You may also be interested in...
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.